pika rabies vaccine
Vaccineexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Feb 1, 2015 (NCT02657161)
Timeline
Indications
Studied for
Mechanism of action
- Lyssavirus rabiesImmunity, active
Lyssavirus rabies immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pika rabies vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05667974 | Phase 3 | Apr 6, 2023 | Yisheng Biopharma |
| NCT02956421 | Phase 2 | Feb 1, 2016 | Singapore General Hospital, Yisheng Biopharma |
| NCT02657161 | Phase 1 | Feb 1, 2015 | Duke University, Singapore General Hospital, Yisheng Biopharma |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Yisheng Biopharma | For profit | 3 | 3 | 3 | 2015 |
| Singapore General Hospital | Academic/Hospital | 2 | 0 | 2 | 2015 |
| Duke University | Academic/Hospital | 1 | 0 | 1 | 2015 |
3 organizations
Page 1 / 1